Free Trial

Intech Investment Management LLC Buys New Position in Genpact Limited (NYSE:G)

Genpact logo with Business Services background
Remove Ads

Intech Investment Management LLC acquired a new position in shares of Genpact Limited (NYSE:G - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 134,655 shares of the business services provider's stock, valued at approximately $5,783,000. Intech Investment Management LLC owned approximately 0.08% of Genpact at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its holdings in shares of Genpact by 192.8% during the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock worth $122,701,000 after purchasing an additional 2,060,595 shares during the last quarter. Tandem Investment Advisors Inc. lifted its position in Genpact by 390.5% during the fourth quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider's stock worth $91,480,000 after buying an additional 1,695,706 shares during the period. Victory Capital Management Inc. boosted its stake in Genpact by 18.1% in the 4th quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock worth $423,205,000 after buying an additional 1,511,790 shares during the last quarter. Geode Capital Management LLC grew its holdings in Genpact by 12.6% in the 3rd quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider's stock valued at $148,142,000 after buying an additional 413,646 shares during the period. Finally, Swiss National Bank acquired a new position in shares of Genpact during the 4th quarter valued at about $14,298,000. Institutional investors and hedge funds own 96.03% of the company's stock.

Remove Ads

Genpact Stock Up 0.9 %

Shares of G traded up $0.46 during midday trading on Friday, reaching $49.90. 3,102,046 shares of the company were exchanged, compared to its average volume of 1,296,134. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a 1-year low of $30.23 and a 1-year high of $56.76. The company has a market cap of $8.77 billion, a price-to-earnings ratio of 17.57, a P/E/G ratio of 1.84 and a beta of 1.16. The stock has a 50-day moving average price of $50.27 and a 200-day moving average price of $44.66.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. Research analysts expect that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.36%. This is an increase from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio (DPR) is presently 23.94%.

Insider Buying and Selling

In related news, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares in the company, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.80% of the company's stock.

Analysts Set New Price Targets

G has been the topic of several research analyst reports. Mizuho raised their target price on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and boosted their price objective for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and upped their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Finally, Needham & Company LLC lifted their target price on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a report on Friday, February 7th. Six investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Genpact has an average rating of "Hold" and a consensus price target of $48.44.

Get Our Latest Research Report on G

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Recommended Stories

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads